Trinity Biotech is not in compliance with Nasdaq's bid price and market value requirements.

From GlobeNewswire: 2025-03-14 16:30:00

Trinity Biotech plc received notices from Nasdaq that it is not in compliance with minimum bid price and market value of publicly held shares requirements. The Company has 180 days to regain compliance with the bid price requirement of US $1.00 per share. If compliance is not met, Trinity may be eligible for an additional 180-day grace period. The Company also has 180 days to meet the minimum market value of publicly held shares requirement of US $15,000,000. Trinity’s management intends to actively monitor and cure the deficiencies within the prescribed grace period to maintain its listing on the Nasdaq Global Market.



Read more at GlobeNewswire: Trinity Biotech Receives Non-Compliance Notice Regarding